Patent Assignment
Reel/Frame 032380/0226
Release of Patent Security Interest
Recorded: 2014-03-03
Pages: 10
Assignor
MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Executed: 2014-02-28
Assignee
ENDO PHARMACEUTICALS SOLUTIONS INC.
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
Covered Properties
(46)
Platelet Activating Factor Antagonist and Methods of Use Therefor
Patent:
4,973,603 →
Application:
07/350,391 →
Preparation of Homogeneous Hydrogel Copolymers
Patent:
5,266,325 →
Application:
07/621,346 →
Manufacture of Water-Swellable Hydrophilic Articles and Drug Delivery Devices
Patent:
5,292,515 →
Application:
08/041,523 →
Compound for Inhibiting Hiv Infectivity
Patent:
5,614,559 →
Application:
08/245,619 →
Efficient Method to Conduct Large-Scale Genome Sequencing
Patent:
5,670,321 →
Application:
08/438,567 →
Compound for Inhibiting Hiv Infectivity
Patent:
5,677,343 →
Application:
08/467,725 →
Compound for Inhibiting Hiv Infectivity
Patent:
6,075,050 →
Application:
08/467,728 →
Sulfonic Acid and Aldehyde Condensation Polymers for Preventing Pregnancy
Patent:
5,958,399 →
Application:
08/847,019 →
Compound for Inhibiting Hiv Infectivity
Patent:
6,365,625 →
Application:
09/398,571 →
Methods and Compositions for Alleviating Stuttering
Patent:
6,855,721 →
Application:
09/628,803 →
Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
Patent:
6,361,797 →
Application:
09/646,066 →
Methods of Treating Obsessive-Compulsive Disorder
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone
Implanting Device and Method of Using Same
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Methods and Compositions for Alleviating Stuttering
Compositions and Methods for Treating Precocious Puberty
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2OXO-Hexyl)-1-Isoidolinone
Use of Pagoclone for the Treatment of Social Anxiety Disorder
Controlled Release Formulations of Octreotide
Method for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone)
Method of Inserting an Object Under the Skin
Implant Device Release Agents and Methods of Using Same
Delivery of Dry Formulations of Octreotide
Controlled Release Formulations of Octreotide
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Compositions and Methods for the Treatment of Bladder Cancer
Application:
12/324,019 →
Publication:
US 2009/0214634
Implantable Device for the Delivery of Naltrexone and Methods of Use Thereof
Application:
12/351,617 →
Publication:
US 2009/0208540
Sulfonic Acid and Aldehyde Condensation Polymers for the Treatment and Prevention of Hpv
Combination Treatment for Bladder Cancer
Implantation Device for Subcutaneous Implatation of an Object Under the Skin
An Implantable Device for the Sustained Release of a Polypeptide
Octreotide Implant Having a Release Agent and Uses Thereof
Implantable Device for the Delivery of Risperidone and Methods of Use Thereof
Controlled Release Formulations of Octreotide
Application:
12/814,276 →
Publication:
US 2011/0009338
Delivery of Dry Formulations of Octreotide
Application:
12/814,286 →
Publication:
US 2010/0247594
Controlled Release Formulations of Octreotide
A Method of Manufacturing an Implantable Device
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Long Term Drug Delivery Devices with Polyurethane-Based Polymers and Their Manufacture
Methods and Compositions for Alleviating Stuttering
Octreotide Implant Having a Release Agent
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application:
13/121,152 →
Publication:
US 2011/0244015
Implantable Device for the Delivery of Histrelin and Methods of Use Thereof
Application:
13/121,391 →
Publication:
US 2011/0236456
Implanting Device
Patent:
492,995 →
Application:
29/179,382 →
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Feb 27, 2014
From: PROCEPT, INC.
To: HEAVENLYDOOR.COM, INC.
Reel/Frame 032366/0915 →
Merger and Change of Name
Feb 27, 2014
From: HEAVENLYDOOR.COM, INC.
To: PALIGENT INC.
Reel/Frame 032366/0904 →
Grant of Security Interest in Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Assignment of Assignor's Interest
Nov 19, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: BRAEBURN PHARMACEUTICALS BVBA SPRL
Reel/Frame 034206/0253 →
Assignment of Assignor's Interest
Jun 3, 2016
From: BRAEBURN PHARMACEUTICALS BVBA SPRL
To: BRAEBURN PHARMACEUTICALS, INC.
Reel/Frame 038800/0527 →
Assignment of Assignor's Interest
Jan 25, 2017
From: ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS VALERA INC.
To: BRAEBURN PHARMACEUTICALS, INC.
Reel/Frame 041081/0926 →
Assignment of Assignor's Interest
Jan 30, 2017
From: VALERA PHARMACEUTICALS, INC.
To: INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 041123/0514 →
Change of Name
Jan 30, 2017
From: VALERA PHARMACEUTICALS, INC.
To: ENDO PHARMACEUTICALS VALERA INC.
Reel/Frame 041564/0401 →
Release of Security Interest
Feb 3, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 041171/0936 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
Security Interest
Jun 8, 2017
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0001 →
Confirmatory Grant of Security Interest in United States Patents
Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
Confirmatory Grant of Security Interest in United States Patents
Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
Assignment of Assignor's Interest
Apr 23, 2024
From: ENDO PHARMACEUTICALS SOLUTIONS INC.
To: ENDO USA, INC.
Reel/Frame 067198/0892 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0491 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0542 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
Assignment of Assignor's Interest
Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
Assignment of Assignor's Interest
Jun 21, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067800/0107 →
Security Interest
Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest
Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
Security Interest
Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068401/0390 →
Security Interest
Aug 26, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068401/0578 →